Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens

World Journal of Gastroenterology

Volumn 12, Issue 33, 2006, Pages 5368-5374

  Roohi, Azam ^a   Yazdani, Yaghoub ^a   Khoshnoodi, Jalal ^a   Jazayeri, Seyed Mohammad ^a   Carman, William F ^b   Chamankhah, Mahmood ^c   Rashedan, Manley ^c   Shokri, Fazel ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Avesina Research Center   (Iran)

Author keywords

Epitope mapping; Hepatitis B surface antigen; Hepatitis B virus; Monoclonal antibody; Mutant; Vaccination

Indexed keywords

ASPARAGINE; EPITOPE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; METHIONINE; MONOCLONAL ANTIBODY; MUTANT PROTEIN; PROLINE; SERINE; THREONINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE MUTATION; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; IMMUNOREACTIVITY; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN DETERMINATION;

EID: 33749419861     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i33.5368     Document Type: Article

References (42)

1. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci 2005; 2: 50-57
2. Alper CA. The human immune response to hepatitis B surface antigen. Exp Clin Immunogenet 1995; 12: 171-181
3. Shokri F, Jafarzadeh A. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates. Vaccine 2001; 19: 4544-4548
4. Jafarzadeh A, Kardar GA, Khoshnoodi J, Shokri F. Down-regulation of IL-12 production in healthy non-responder neonates to recombinant hepatitis B vaccine. Irn Biomed J 2004; 8: 41-45
5. Hohler T, Meyer CU, Notghi A, Stradmann-Bellinghausen B, Schneider PM, Starke R, Zepp F, Sanger R, Clemens R, Meyer zum Buschenfelde KH, Rittner C. The influence of major histocompatibility complex class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg. Hum Immunol 1998; 59: 212-218
6. Kardar GA, Jeddi-Tehrani M, Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine. Scand J Immunol 2002; 55: 311-314
7. Jafarzadeh A, Shokri F. The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates. Clin Exp Immunol 2003; 131: 451-456
8. Kruger A, Adams P, Hammer J, Bocher WO, Schneider PM, Rittner C, Hoehler T. Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies. Clin Exp Immunol 2005; 140: 325-332
9. Shokrgozar MA, Shokri F. Enumeration of hepatitis B surface antigen-specific B lymphocytes in responder and non-responder normal individuals vaccinated with recombinant hepatitis B surface antigen. Immunology 2001; 104: 75-79
10. Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 1990; 345: 258-260
11. Soroosh P, Shokri F, Azizi M, Jeddi-Tehrani M. Analysis of T-cell receptor beta chain variable gene segment usage in healthy adult responders and nonresponders to recombinant hepatitis B vaccine. Scand J Immunol 2003; 57: 423-431
12. Locarnini S. Molecular virology of hepatitis B virus. Semin Liver Dis 2004; 24 Suppl 1: 3-10
13. Chen WN, Oon CJ. Hepatitis B virus mutants: an overview. J Gastroenterol Hepatol 2002; 17 Suppl: S497-499
14. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-229
15. Norder H, Courouce AM, Magnius LO. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 1992; 73 (Pt 12): 3141-3145
16. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 2005; 32: 102-112
17. Zuckerman JN, Zuckerman AJ. Mutations of the surface protein of hepatitis B virus. Antiviral Res 2003; 60: 75-78
18. Coleman PF, Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999; 59: 19-24
19. Roohi A, Khoshnoodi J, Zarnani AH, Shokri F. Epitope mapping of recombinant hepatitis B surface antigen by murine monoclonal antibodies. Hybridoma (Larchmt) 2005; 24: 71-77
20. Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GK, Carman WF. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000; 31: 1176-1182
21. Zaaijer HL, Vrielink H, Koot M. Early detection of hepatitis B surface antigen and detection of HBsAg mutants: a comparison of five assays. Vox Sang 2001; 81: 219-221
22. Shizuma T, Hasegawa K, Ishikawa K, Naritomi T, Iizuka A, Kanai N, Ogawa M, Torii N, Joh R, Hayashi N. Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus. J Gastroenterol 2003; 38: 244-253
23. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-329
24. Thakur V, Kazim SN, Guptan RC, Hasnain SE, Bartholomeusz A, Malhotra V, Sarin SK. Transmission of G145R mutant of HBV to an unrelated contact. J Med Virol 2005; 76: 40-46
25. Lee PJ, Chang LY, Lee CY, Huang LM, Chang MH. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 1997; 176: 427-430
26. Hsu HY, Chang MH, Ni YH, Chen HL. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 2004; 53: 1499-1503
27. Koppelman MH, Zaaijer HL. Diversity and origin of hepatitis B virus in Dutch blood donors. J Med Virol 2004; 73: 29-32
28. Zuckerman AJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 2000; 355: 1382-1384
29. Fitzsimons D, Francois G, Hall A, McMahon B, Meheus A, Zanetti A, Duval B, Jilg W, Bocher WO, Lu SN, Akarca U, Lavanchy D, Goldstein S, Banatvala J, Damme PV. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23: 4158-4166
30. Jolivet-Reynaud C, Lesenechal M, O'Donnell B, Becquart L, Foussadier A, Forge F, Battail-Poirot N, Lacoux X, Carman W, Jolivet M. Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies. J Med Virol 2001; 65: 241-249
31. Cooreman MP, van Roosmalen MH, te Morsche R, Sunnen CM, de Ven EM, Jansen JB, Tytgat GN, de Wit PL, Paulij WP. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations. Hepatology 1999; 30: 1287-1292
32. Manson MM. Methods in molecular biology-immunochemical protocols. Vol. 10, 1st ed. New Jersey: The humana press, Inc. 1992: 137-142
33. Sambrook J, Russel DW. Molecular cloning-A laboratory manual. Vol. 1, 3rd ed. New York: Cold sprig harbor laboratory press, 2000: 1119-1122
34. Waters JA, Brown SE, Steward MW, Howard CR, Thomas HC. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res 1992; 22: 1-12
35. Maillard P, Pillot J. At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis. Res Virol 1998; 149: 153-161
36. Shokrgozar MA, Shokri F. Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine. Vaccine 2002; 20: 2215-2220
37. Zuckerman JN, Zuckerman AJ. Mutations of the surface protein of hepatitis B virus. Antiviral Res 2003; 60: 75-78
38. Ashton-Rickardt PG, Murray K. Mutants of the hepatitis B virus surface antigen that define some antigenically essential residues in the immunodominant a region. J Med Virol 1989; 29: 196-203
39. Kfoury Baz EM, Zheng J, Mazuruk K, Van Le A, Peterson DL. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays. Transfus Med 2001; 11: 355-362
40. Chen YC, Delbrook K, Dealwis C, Mimms L, Mushahwar IK, Mandecki W. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci USA 1996; 93: 1997-2001
41. Chong-Jin O, Wei Ning C, Shiuan K, Gek Keow L. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J Infect Dis 1999; 179: 259-263
42. Chen WN, Oon CJ, Toh I. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common "a" determinant. Am J Gastroenterol 2000; 95: 1098-1099